Data updated: Mar 10, 2026
ATOVAQUONE
ATOVAQUONE
Approved 2014-03-18
9
Indications
--
Phase 3 Trials
11
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2014-03-18
- Routes
- ORAL
- Dosage Forms
- SUSPENSION
Companies
Lupin BIONPHARMA PAI HOLDINGS GLENMARK SPECLT ABHAI LLC CHARTWELL RX HETERO LABS LTD III Apotex AMNEAL PHARMS
Active Ingredient: ATOVAQUONE
Website: ↗
ATOVAQUONE Approval History
Loading approval history...
What ATOVAQUONE Treats
9 FDA approvalsOriginally approved for its first indication in 2014 . Covers 9 distinct patient populations.
- Other (9)
Other
(9 approvals)- • Approved indication (Mar 2014)Letter
- • Approved indication (Apr 2017)
- • Approved indication (Oct 2017)
- • Approved indication (Sep 2018)
- • Approved indication (Oct 2018)
- • Approved indication (Nov 2018)
- • Approved indication (May 2019)
- • Approved indication (Mar 2021)
- • Approved indication (Oct 2021)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
ATOVAQUONE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.